Tuomas Kiviniemi
MD, PhD, FESC
tuoski@utu.fi ORCID identifier: https://orcid.org/0000-0002-0908-3741 |
Cardiology; Clinical trials; Atrial fibrillation; Coronary artery disease; Percutaneous coronary intervention; Wearables; Anticoagulation; Bleeding; Translational research
Professor of cardiology, PI in CAREFIB and LAA-CLOSURE
Tuomas Kiviniemi, MD, PhD, FESC, is Professor of Cardiology at the University of Turku and Chief Physician at the Heart Center, Turku University Hospital. His clinical and academic work focuses on interventional cardiology, atrial fibrillation, and cardiovascular risk in patients undergoing cardiac procedures. He also serves as President of the Finnish Cardiac Society for the 2024–2026 term, contributing nationally to cardiovascular care development and professional education.
Professor Kiviniemi completed his medical and doctoral degrees at the University of Turku and later broadened his research expertise during a research fellowship at Brigham and Women’s Hospital, Harvard Medical School. His research integrates clinical trials, biomarker studies, translational science, and outcome research in percutaneous and surgical cardiac interventions. He leads the multidisciplinary CAREFIB Consortium, which encompasses several major investigator-initiated studies, including CAREBANK, CAREiCON and the LAA-CLOSURE randomized trial program investigating stroke prevention strategies in atrial fibrillation.
His scientific output includes peer-reviewed publications, book chapters, trial leadership roles, and long-term collaborations with computational medicine, imaging, and device-innovation groups.
In addition to his academic duties, Professor Kiviniemi is a frequently invited expert in the European Society of Cardiology community, contributing as an abstract reviewer, session chair, and presenter in acute coronary syndromes and interventional cardiology themes.
At the national level, he has served as a long-standing member and chair within the Finnish Cardiac Society, holding multiple leadership and editorial roles. As President of the Society 2024-2026, he advanced cardiovascular education, guidelines, and professional collaboration across Finland.
Professor Kiviniemi’s current research interests span atrial fibrillation detection technologies, outcomes after cardiac surgery, advanced imaging, and digital health solutions. His work continues to bridge clinical cardiology with engineering, data science, and translational discovery, supporting the University of Turku’s strategic strengths in cardiovascular medicine.
At the University of Turku, Professor Kiviniemi is actively involved in supervising doctoral trainees in cardiology, and he has mentored more than ten completed PhD theses. His teaching activities also include specialist training and contributions to national cardiology textbooks.
- Usefulness of troponin T to predict short-term and long-term mortality in patients after hip fracture. (2014)
- American Journal of Cardiology
(A1 Refereed original research article in a scientific journal) - CHADS2 and CHA2DS2-VASc scores as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention (2013)
- European Heart JournalJournal of Invasive Cardiology
(Other publication) - Erratum to: Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome – insights from the BASE-ACS trial (2013)
- International Journal of Cardiovascular Imaging
(A1 Refereed original research article in a scientific journal) - Performance of bleeding risk-prediction scores in patients with atrial fibrillation undergoing percutaneous coronary intervention (2013)
- European Heart Journal
(Other publication) - Renal impairment and prognosis of patients with AF undergoing PCI - The AFCAS trialImpaired ATP-Induced Coronary Blood Flow and Diminished Aortic NTPDase Activity Precede Lesion Formation in Apolipoprotein E-Deficient Mice (2013)
- European Heart JournalAmerican Journal of Pathology
(Other publication) - Thrombocytopenia in Patients With Atrial Fibrillation on Oral Anticoagulation Undergoing Percutaneous Coronary Intervention (2013)
- American Journal of Cardiology
(A1 Refereed original research article in a scientific journal) - Vascular Healing Early After Titanium-Nitride-Oxide-Coated Stent Implantation Assessed by Optical Coherence Tomography (2013)
(A1 Refereed original research article in a scientific journal) - Comparison of additional versus no additional heparin during therapeutic oral anticoagulation in patients undergoing percutaneous coronary intervention (2012)
- American Journal of Cardiology
(A1 Refereed original research article in a scientific journal) - Early Vascular Healing After Endothelial Progenitor Cell Capturing Stent Implantation (2012)
- Journal of Invasive Cardiology
(A1 Refereed original research article in a scientific journal) - (2012)
(A1 Refereed original research article in a scientific journal)
- CAREiCON01.09.2024 - 31.08.2027
- Internal Medicine
- LAA-CLOSURE01.09.2024 - 31.08.2028
- Internal Medicine
- MIRACLE01.10.2023 - 30.09.2027
- Internal Medicine
- CAREBANK STS01.01.2023 - 31.12.2028
- Internal Medicine
- CAREBANK01.01.2021 - 31.12.2025
- Internal Medicine
- KLL Moore4Medical01.06.2020 - 30.09.2023
- Internal Medicine



